|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Epivir-HBV (Lamivudine). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view all available reports.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (8)
Cases resulting in a serious event (7)
Cases resulting in death (2)
Cases resulting in hospitalization (2)
Cases resulting in other serious reactions (4)
Adverse event in 36 year old male receiving Epivir-HBV (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-07-25
Patient: 36 year old male
Adverse reactions / side effects: Renal Failure, Liver Transplant Rejection, Treatment Noncompliance, Asthenia, Hepatitis B, Collapse of Lung
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir-HBV (Lamivudine)
Other drugs received by patient: Prograf; Ursodiol; Coumadin; Synthroid; Metoprolol Succinate
Adverse event in 57 year old male receiving Epivir-HBV (Lamivudine)
Reported by a individual with unspecified qualification from Japan on 2007-05-04
Patient: 57 year old male
Adverse reactions / side effects: Hepatitis B E Antigen Positive, Disease Recurrence, Hepatic Failure, Viral Mutation Identified, Hepatitis B, Oesophageal Varices Haemorrhage, Pathogen Resistance
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Epivir-HBV
Indication: Hepatitis B
Start date: 2001-12-01
Interferon Alfa (Formulation Unknown) (Interferon Alfa)
Adverse event in 57 year old male receiving Epivir-HBV (Lamivudine)
Reported by a physician from Japan on 2007-04-10
Patient: 57 year old male
Adverse reactions / side effects: Condition Aggravated, Hepatitis B
Suspect drug(s):
Epivir-HBV (Lamivudine)
Other drugs received by patient: Ursodiol; Ranitidine Hydrochloride; Frusemide; Spironolactone; Protein Supplement
Adverse event in 42 year old male receiving Epivir-HBV (Lamivudine)
Reported by a individual with unspecified qualification from France on 2007-02-22
Patient: 42 year old male
Adverse reactions / side effects: Alanine Aminotransferase Increased, Transaminases Increased
Suspect drug(s):
Epivir-HBV
Indication: Hepatitis B Virus
Start date: 2001-09-01
Adefovir Dipivoxil KIT
Indication: Hepatitis B
Start date: 2003-07-01
Other drugs received by patient: Interferon Alfa-2A
Adverse event in 25 year old male receiving Epivir-HBV (Lamivudine)
Reported by a individual with unspecified qualification from Turkey on 2007-02-15
Patient: 25 year old male
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Drug Resistance, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Suspect drug(s):
Epivir-HBV
Indication: Hepatitis
Interferon (Formulation Unknown) (Interferon)
Indication: Hepatitis
Adverse event in receiving Epivir-HBV (Lamivudine)
Reported by a individual with unspecified qualification from France on 2007-01-31
Patient:
Adverse reactions / side effects: Drug Resistance, Viral Infection, Hepatitis B Virus, Condition Aggravated, Gene Mutation Identification Test Positive
Suspect drug(s):
Epivir-HBV
Indication: Hepatitis B Virus
Adefovir Dipivoxil KIT
Indication: Hepatitis B
Adverse event in 51 year old male receiving Epivir-HBV (Lamivudine)
Reported by a individual with unspecified qualification from Germany on 2007-01-26
Patient: 51 year old male
Adverse reactions / side effects: Drug Resistance, Hepatic Failure, Pathogen Resistance, Infection
Suspect drug(s):
Epivir-HBV (Lamivudine)
Adverse event in 57 year old male receiving Epivir-HBV (Lamivudine)
Reported by a individual with unspecified qualification from Canada on 2007-01-18
Patient: 57 year old male
Adverse reactions / side effects: Oral Intake Reduced, Confusional State, Hepatic Necrosis, Lymphadenopathy, Pruritus, Coagulopathy, Coma, Abdominal Tenderness, Thrombocytopenia, Refusal of Treatment by Patient, International Normalised Ratio Increased, Encephalopathy, Respiratory Failure, Chromosomal Mutation, Leukocytosis, Hepatitis B
Adverse event resulted in: death
Suspect drug(s):
Epivir-HBV (Lamivudine)
Other drugs received by patient: Cancer Chemotherapy
|
